Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Schweizerische Medizinische Wochenschrift|February 9, 1991
[The treatment of acute lymphatic leukemia in adults: pilot project with intensive early therapy without a maintenance phase]M Wernli, A Gratwohl, V von Fliedner, et al.British Journal of Haematology|May 1, 1994
Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. Working Party on Leukaemia of the Swiss Group for Epidemiologic and Clinical Cancer Research (SAKK)M Wernli, A Tichelli, V von Fliedner, et al.Bone Marrow Transplantation|January 27, 2009
Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphomaM Heizmann, A C O'Meara, P R Moosmann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicityM M Borner, J Bernhard, D Dietrich, et al.British Journal of Cancer|April 1, 2004
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trialR Morant, J Bernhard, D Dietrich, et al.European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II studyR Morant, S-F Hsu Schmitz, J Bernhard, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2005
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)M Ghielmini, K Rufibach, G Salles, et al.Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancerE H Tan, A Szczesna, M Krzakowski, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II studyA von Rohr, S-F H Schmitz, A Tichelli, et al.Pageof 6